Australia · Delayed Price · Currency is AUD · OptionAvecho Biotechnology Statistics
Total Valuation
ASX:AVEOA has a market cap or net worth of AUD 22.21 million. The enterprise value is 16.34 million.
| Market Cap | 22.21M |
| Enterprise Value | 16.34M |
Important Dates
The last earnings date was Friday, November 28, 2025.
| Earnings Date | Nov 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +9.80% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 1.90B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 16.09 |
| PB Ratio | 26.92 |
| P/TBV Ratio | 26.92 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 18.64 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.51 |
| EV / Sales | 11.83 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.62, with a Debt / Equity ratio of 0.07.
| Current Ratio | 4.62 |
| Quick Ratio | 4.46 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -29.15 |
Financial Efficiency
Return on equity (ROE) is -143.71% and return on invested capital (ROIC) is -83.61%.
| Return on Equity (ROE) | -143.71% |
| Return on Assets (ROA) | -33.53% |
| Return on Invested Capital (ROIC) | -83.61% |
| Return on Capital Employed (ROCE) | -61.87% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 92,037 |
| Profits Per Employee | -241,517 |
| Employee Count | 15 |
| Asset Turnover | 0.21 |
| Inventory Turnover | 4.46 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 48.03 |
| Average Volume (20 Days) | 2,977,552 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:AVEOA had revenue of AUD 1.38 million and -3.62 million in losses. Loss per share was -0.00.
| Revenue | 1.38M |
| Gross Profit | 859,631 |
| Operating Income | -3.50M |
| Pretax Income | -3.62M |
| Net Income | -3.62M |
| EBITDA | -3.36M |
| EBIT | -3.50M |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 5.93 million in cash and 57,123 in debt, with a net cash position of 5.88 million.
| Cash & Cash Equivalents | 5.93M |
| Total Debt | 57,123 |
| Net Cash | 5.88M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 825,160 |
| Book Value Per Share | 0.00 |
| Working Capital | 5.54M |
Cash Flow
| Operating Cash Flow | 1.19M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 62.27%, with operating and profit margins of -253.71% and -262.41%.
| Gross Margin | 62.27% |
| Operating Margin | -253.71% |
| Pretax Margin | -262.41% |
| Profit Margin | -262.41% |
| EBITDA Margin | -243.67% |
| EBIT Margin | -253.71% |
| FCF Margin | n/a |
Dividends & Yields
ASX:AVEOA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.80% |
| Shareholder Yield | n/a |
| Earnings Yield | -16.31% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ASX:AVEOA has an Altman Z-Score of -52.35 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -52.35 |
| Piotroski F-Score | 5 |